Merck Manual

Please confirm that you are a health care professional

Loading

Nucleic Acid–Based Identification Methods for Infectious Disease

By

Maria T. Vazquez-Pertejo

, MD, Wellington Regional Medical Center

Last full review/revision Jun 2020| Content last modified Jun 2020
Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version

Nucleic acid–based (molecular) identification has become commonplace in clinical settings; the resulting rapid identification allows the patient to be placed on specific antimicrobial therapy and avoid prolonged management on empiric, potentially inappropriate drugs.

Nucleic acid–based methods detect organism-specific DNA or RNA sequences extracted from the microorganism. Sequences may or may not be amplified in vitro.

Nucleic acid–based methods are generally specific and highly sensitive and can be used for all categories of microbes. Results can be provided rapidly. Because each test typically is specific to a single organism, the clinician must know the diagnostic possibilities and request tests accordingly. For example, if a patient has symptoms suggesting influenza but the influenza season is over, doing a more general viral diagnostic test (eg, viral culture) rather than a specific flu test is better because another virus (eg, parainfluenza, adenovirus) may be the cause.

Recent advances have led to the development of multiplex assays, in which a single nucleic acid–based test can detect and differentiate between ≥ 2 causative microorganisms. Multiplex assays are usually less sensitive than single-target, qualitative assays. They may also be less specific; unanticipated positive results, inconsistent with the patient's clinical picture, should be regarded with caution. Multiplex assays are currently available for detecting biological warfare agents.

Nucleic acid–based tests are qualitative, but quantification methods exist for a limited but increasing number of infections (eg, hepatitis B, hepatitis C, HIV, cytomegalovirus, human T-cell lymphotropic virus); these methods can be useful for diagnosis and for monitoring response to treatment.

Unamplified testing

Techniques that target nucleic acid sequences but do not require amplification of those sequences are usually restricted to situations in which the organism has been first cultured or is present in high concentration in the specimen (eg, in pharyngitis caused by group A Streptococcus, in genital infections caused by Chlamydia trachomatis or Neisseria gonorrhoeae).

Nucleic acid amplification

Nucleic acid amplification techniques take tiny amounts of DNA or RNA, replicate them many times, and thus can detect minute traces of an organism in a specimen, avoiding the need for culture. These techniques are particularly useful for organisms that are difficult to culture or identify using other methods (eg, viruses, obligate intracellular pathogens, fungi, mycobacteria, some other bacteria) or that are present in low numbers.

These tests may involve

  • Target amplification (eg, polymerase chain reaction [PCR], reverse transcriptase–PCR [RT-PCR], strand displacement amplification, transcription amplification)

  • Signal amplification (eg, branched DNA assays, hybrid capture)

  • Probe amplification (eg, ligase chain reaction, cleavase-invader, cycling probes)

  • Postamplification analysis (eg, sequencing of the amplified product, microarray analysis, and melting curve analysis, as is done in real-time PCR)

Appropriate specimen collection and storage before arrival at the molecular diagnostic laboratory are critical. Because amplification methods are so sensitive, false-positive results from trace contamination of the specimen or equipment can easily occur.

Despite high sensitivity, false-negative results sometimes occur even when a patient is symptomatic (eg, in West Nile virus infection). False-negative results can be minimized by the following:

  • Avoiding use of swabs with wooden shafts or cotton tips (the swab that has been validated for the amplification assay must be used)

  • Transporting specimens rapidly

  • Freezing or refrigerating specimens if transport is likely to take > 2 hours

Freezing is the typical storage method for nucleic acid amplification assays. However, specimens should be refrigerated rather than frozen if labile viruses (eg, varicella-zoster virus, influenza virus, HIV-2) are suspected or if viral cultures are also to be done (frozen specimens may not be usable for standard cultures).

Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version

Also of Interest

Videos

View All
Overview of Zika Virus Infection
Video
Overview of Zika Virus Infection
3D Models
View All
SARS-CoV-2
3D Model
SARS-CoV-2

SOCIAL MEDIA

TOP